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SUMMARY 
 
In recent years, Rhodococcus equi has emerged as pathogen of importance in respiratory and non-respiratory 
infectious diseases of animals and humans. Its distribution is worldwide and incidence of disease is increasing in non-
equine species like cats and humans. Sporadic infection in human and cat is hypothesized to infect 
immunocompromised cases largely. While predominantly in foals, infection is quite endemic/epidemic in nature 
depending on virulence of strain, and incidence is 10 – 20% since birth till weaning. Mode of acquisition is quite 
variable in humans, cats and foals and depends on the route of exposure. Pathogenesis is well understood in natural 
host but in cats and humans it is still in its infancy because of the manifestation of unusual cases with low to no 
exposure to contaminated elements. Clinical signs depend on the site of infection but respiratory manifestations are 
quite common in foals and human cases. In cats extra-pulmonary disorders are hypothesized as more common 
presentation. Definitive diagnosis is based on the microbiological culture and cytology from tracheobronchial aspirate 
for respiratory cases and site of sample for non-respiratory lesions. White blood cells and fibrinogen have some 
correlation in degree of diagnosis in foals but not in cats and humans. Macrolides especially clarithromycin along with 
rifampin are considered best combination at the moment and recently resistance is being reported against erythromycin 
and rifampin. In foals, consensus statements by ACVIM published detailed control and preventions but in humans and 
cats so far hygiene and isolation of infected patients are for the time being the methods to control nosocomial spread. 
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INTRODUCTION  
 
The word “Rhodococcus” was firstly described by a 
German botanist “Wilhelm Friedrich Zopf” in 1891 
during classification of pigment producing bacterial and 
fungal organisms (Zopf, 1891). Later on, the members 
(organisms similar to nocardiaform and mycobacterial 
species) of inappropriately named rhodochrous complex 
were also included in genus Rhodococcus, redefined in 
1977 (Goodfellow & Alderson, 1977).  
The organism was formerly known as 
Corynebacterium equi and Mycobacterium equi 
(Finnerty, 1992; Shinji Takai, 1997). Currently, 
Rhodococcus equi (R. equi) is classified in family 
Nocardiaceae and order Actinomycetales but a proposal 
had been made in 2013 to reclassify this organism as 
Prescottia equi (Jones et al., 2013). R. equi is ubiquitous, 
facultative, intracellular, non-motile, telluric, gram-
positive coccobacillus bacterium that is capable of 
infecting macrophages by interfering phagolysosomal 
fusion and has zoonotic potential as well (Muscatello et 
al., 2007; Passamonti et al., 2011; Trevejo et al., 2005). 
R. equi might appear as coccoid or rod depending on the 
growth environment and the life cycle’s phase (Hines, 
2014). 
 
EPIDEMIOLOGY OF Rhodococcus Equi  
 
R. equi is distributed worldwide including Asia, 
Europe, Australia, South and North America continents 
with highly variable pattern (Khurana, 2015). This 
bacterium  
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can be cultured from the soil, faeces of herbivores 
especially horses and horse farm and around equine 
breeding area because of its widespread nature. Also, its 
presentation is virtually considered in all equine related 
areas (Barton & Hughes, 1984; Shinji Takai, 1997; Shinji 
Takai et al., 1986). Optimal conditions for bacterial 
growth are 30 degree celsius temperature, aerobic 
environment with pH between 7.5 – 8.0 (best 7.3) and 
faecal enriched soil as compare to soil alone. Organic 
acids present in horse dung are supportive elements for 
the bacterial survival and growth (Hughes & Sulaiman, 
1987).  
Very first clinical case of Corynebacterium equi 
(classified later in 1977 as R. equi) related respiratory 
illness in a foal was reported in Sweden (Magnusson, 
1923). Recently, R. equi has been isolated as resident 
aerobic microbiota of a healthy nasal cavity in human 
which can become opportunistic pathogen in 
immunocompromised patients (Rasmussen et al., 2000). 
Furthermore, It has been isolated abundantly from 
contaminated soil surface (Shinji Takai et al., 1986), 
infected or exposed foals (actual colonization in intestine) 
and adult horse faeces as passive intestinal carriage from 
contaminated soil (Shinji Takai, 1997). Also, this 
pathogen has been isolated from contaminated wounds, 
abscess and pyogranulomatous lesions of muscles, bones, 
body organs like liver, spleen, lymph nodes, eyes, 
trachea, vagina, joints and lungs of infected foals, cats, 
dogs, goats, cattle including immunocompromised 
humans and many more wild animal species like 
monkeys and wild boars too (Aslam et al., 2019; Bryan et 
al., 2017; Fairley & Fairley, 1999; Gunew, 2002; 
Khurana, 2015; Passamonti et al., 2011; Stranahan et al., 
2018; Shinji Takai et al., 2001; Shinji Takai et al., 2003). 
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Incidence and host range among animals 
 
The disease is quite sporadic in nature in non-equine 
hosts like cats, dogs, goats, cattle, monkeys and wild 
boars and very few cases have been reported so far, but it 
can be endemic or epidemic in nature in equine host. 
Generally, the incidence of disease is considered to be 10 
– 20% in foals since birth till weaning, although higher 
cumulative incidence has also been calculated in some 
studies (Cohen, 2014). Pneumonia associated with R. equi 
tends to be confined to younger animal in equines and 
typically seen between the age of 1 to 6 months (Gary 
Muscatello, 2012a). Horses that are more than 1 year are 
rarely affected by this infection but if there is any report, 
most of the time accompanying immunodeficiency factor 
(Cohen, 2014). A previously reported comprehensive 
case study in a 10-years old horse diagnosed with R. equi 
related pleuropneumonia, suggested that perhaps this type 
of infection is being overlooked in adult horses and also 
negated immunodeficiency factor, as it was not proven in 
this particular case (Vengust, et al., 2002).  
R. equi has been considered an emerging pathogen 
causing disease in immunocompromised patients like 
HIV, renal transplant and AIDS patients, although 
immunocompetent people also get infected in rare cases 
(Khurana, 2015).  
The disease has been diagnosed in cat population at 
minimum age of 2 months kitten (suppurative 
bronchopneumonia) until 15 years (extrapulmonary 
lesion) in reported cases till date. Also, extrapulmonary 
form was considered predominant in cat population, and 
inefficient immune system was hypothesized as 
predisposing cause in most of these studies which still 
remained unproven (Aslam et al., 2019; Fairley & 
Fairley, 1999; Gunew, 2002; Passamonti et al., 2011; 
Shinji Takai et al., 2003). In cats, this disease is important 
because < 20% cases of the feline pyothorax occur 
because of non-oropharyngeal infectious agents and R. 
equi is one of them (Barrs & Beatty, 2009). In 
documented cases of a dog population, minimum age 
reported was between 3 to 12 years where pulmonary and 
extra-pulmonary pathologies were found, and also 
immunodeficiency factor was hypothesized as 
predisposing cause (Bryan et al., 2017; Shinji Takai et al., 
2003). In goats, age distribution was between 1 – 4 years 
with pulmonary and extrapulmonary lesions, while in a 
monkey, infection was diagnosed at the age of 6 months 
presented with interstitial pneumonitis (Stranahan et al., 
2018; S. Takai et al., 2001).  
 
Epidemiological factors of disease characterisation 
 
Factors characterising epidemiology of the 
infectious diseases can be related to environment, host 
and infectious agent itself (Lilienfeld et al., 1994). 
Virulence levels of R. equi have been described as: 
avirulent, intermediate and virulent. The type of virulence 
associated proteins (Vaps) and virulence plasmid DNA is 
the determinant of severity of disease in different species 
(Passamonti et al., 2011). In this aspect, three host-
associated virulence plasmid types have been described in 
recent scientific studies, viz. the pVAPA (equine 
specific), pVAPB (porcine specific) and pVAPN found in 
ruminant (bovine) isolates (Witkowski et al., 2016).  
There are emerging reports on isolation of one host 
associated virulence plasmid type from other species like 
pVAPN and pVAPB isolated from human cases which 
are actually bovine and porcine specific, respectively 
(MacArthur et al., 2017). About 20 – 25% cases of 
immunocompromised humans were reported to be 
infected by VapA virulent strain (Shinji Takai et al., 
1995). In dogs and cats only avirulent and VapA positive 
isolates have been reported so far (Shinji Takai et al., 
2003). Because of the close association and high degree 
of similarity of the plasmid profiles of VapA isolates 
from dogs and cats with horses, there are highly likely 
chances that they carried infection from equine-loaded 
premises or perhaps from their environment contaminated 
with R. equi (Passamonti et al., 2011).  
About 50 - 95% of horse farm’s soil have been 
reported to be concentrated by R. equi (Yamshchikov et 
al., 2010). The cumulative incidence of R. equi 
pneumonia is not dependent of soil concentration of 
virulent strain but air-borne concentrations have been 
positively correlated with disease (G Muscatello et al., 
2006). Exposure of the newborn by virulent strain and 
further raring and management was considered a major 
risk factor for disease development. Those foals, born in a 
foaling stall which was exposed heavily to a virulent 
strain were more prone to disease as compared to the 
foals born in pastures and paddocks (Cohen et al., 2005). 
Host factors such as less than 6 months of age (Gary 
Muscatello, 2012a), immune response (naïve or deficient) 
and immune function such as expression of interferon 
gamma are remarkably less in foals as compared to adults 
(Breathnach et al., 2006), and changes in the gene 
expression of leukocytes with ageing in response to R. 
equi can also play a key role in disease development 
(Kachroo et al., 2013). Although there are some studies 
which found that immune function of newborn foals were 
quite conflicting in response to infection or vaccine-based 
immunity development. For example, in one vaccination 
study (live intracellular bacterial or killed or attenuated 
viral), response of newborn foals was not the same as that 
of adults (Ryan & Giguere, 2010; Sturgill et al., 2014). 
On the other hand, in another study, response of 
stimulated interferon gamma was the same by an adult 
horse and a ten-days-old foal (Jacks et al., 2007). Some 
reported predisposing factors of human infection are 
AIDS, HIV, hemolymphatic tumor (usage of steroids), 
renal transplant, corticosteroid therapy, excessive alcohol 
usage, penetrating eye injury, raw carrots ingestion and 
hepatic fistula (Prescott, 1991).  
Conclusively, further work is needed in this area for 
host factor to be considered as the key player in disease 
development. An anecdotal evidence of genetic 
susceptibility to R. equi infection has also been reported 
in a previous study where in some affected stallions and 
mares did not produce same form of disease as with other 
groups, under similar exposure (Halbert et al., 2006).  
 
Mode of transmission 
 
Possible routes of transmission of R. equi are: 
inhalation, inoculation of wound and mucous membranes 
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or transcutaneous infection or contamination of wound, 
ingestion or food-borne transmission, and dissemination 
to distant sites by hematogenous route. In foals, the 
predominant route of bacterial transmission is inhalation 
followed by ingestion (Gary Muscatello, 2012a). 
Contamination of the wound is also rarely reported in this 
specie (Hondalus, 1997).  
In humans, possible routes of R. equi transmission 
are exposure to contaminated manure of domestic animals 
especially foals and soil, inhalation, and inoculation into a 
wound or mucous membrane (Doig et al., 1991; Khurana, 
2015; Weinstock & Brown, 2002; Yamshchikov et al., 
2010). Nosocomial route of infection was also reported in 
the past (Scotton et al., 2000). In a previous study, pet 
animals like cats and dogs infected with R. equi can 
possess some risk of infection to just 
immunocompromised human patients, they are otherwise 
not suggested as source of infection for humans (Shinji 
Takai et al., 2003). Food-borne transmission (like pigs) 
can contribute to the probability of disease development 
in human patients (Makrai et al., 2008). 
Contrary to foals and humans, in cats and dogs; the 
most common route of transmission is transcutaneous 
infection of wounds followed by aerogenous route which 
can finally disseminate to body cavities and organs 
through hematogenous route (Fairley & Fairley, 1999; 
Passamonti et al., 2011; Shinji Takai et al., 2003). A 
recent report on goats documented respiratory-acquired R. 
equi and its further dissemination by hematogenous route 
and some cases of wound contamination also, which may 
hypothesize similar mode of transmissions in domestic 
animals just like the occurrence in in foals, dogs and cats 
(Stranahan et al., 2018). 
 
PATHOGENESIS OF R. Equi 
 
The pathogenesis of R. equi in its natural host foal is 
well understood and well documented by Gary 
Muscatello (2012a), whereas, it is considered an 
emerging pathogen in other accidental or opportunistic 
hosts like dogs, cats, humans, domestic and wild animals 
like goats, cattle, wild boars, and monkeys. It is 
hypothesized that it may act differently in terms of 
pathogenesis in non-equine hosts. Also, it is hypothesized 
that other host’s immune system responds differently 
when infected by R. equi (Aslam et al., 2019; Hondalus, 
1997; Khurana, 2015; Passamonti et al., 2011).  
The infectivity of R. equi is limited to monocyte or 
macrophage lineage where replication also takes place 
(Hondalus & Mosser, 1994) and eventually leads to the 
death of infected cells by inhibition of phagosome-
lysosome fusion. On the other hand, neutrophils are 
considered completely bactericidal in foals (Meijer & 
Prescott, 2004). Consequence of infection is migration of 
large number of inflammatory or protective cells of the 
body which finally lead to granuloma formation (Hines, 
2014). In human, there is little known about the immune 
response to R. equi because of their infectivity with 
avirulent strains of R. equi and inefficient cell-mediated 
immunity (mandatory to control R. equi infection) in 
immunocompromised patients. Hence, they can possess a 
different pathogenesis in future experimental studies 
(Kanaly et al., 1993; Shinji Takai et al., 1994).  
Further work was suggested by previous studies in 
other species like humans, cats, and pigs infected with R. 
equi, because of their unclear pathogenesis and 
predisposing factors, although the same might be true for 
a large range of other non-equine species also like dogs, 
goats, cattle and camels (Aslam et al., 2019; Hondalus, 
1997; Kinne et al., 2011; Makrai et al., 2008; Passamonti 
et al., 2011). 
 
CLINICAL SIGNS OF R. Equi Infection 
 
Because the major route of transmission of infection 
is inhalation and ingestion & principle pathogenicity is 
regarded in equine specie, so lungs and intestines have 
been described as predilection sites in foals by 
manifesting pyogranulomatous bronchopneumonia and 
ulcerative enterotyphlocolitis, respectively (Gary 
Muscatello, 2012a). Although, extrapulmonary disorders 
(EPDs) such as ulcerative lymphangitis, 
pyogranulomatous lymphadenopathies, 
pyogranulomatous hepatitis, peritonitis, pericarditis, 
granulomatous meningitis, subcutaneous abscess, 
immune mediated polysynovitis and haemolytic anaemia, 
osteomyelitis and arthritis type consequences have also 
been reported in foals (Reuss et al., 2009). Manifestation 
of EPDs with primary predilection site’s infection has 
been correlated with poor survival rate of 43% by 82% 
without EPDs (S Giguère et al., 2011). 
In a recent review on R. equi, Khurana (2015) 
documented pneumonia as the most common 
manifestation in humans. Although, extrapulmonary 
disorders like fever, diarrhea, abscess of brain (Corne et 
al., 2002), meninges, peritoneum and thyroid glands, 
lymphadenitis, pericarditis, polysynovitis, osteoarthritis, 
osteomyelitis, colonic polyps (Talanin et al., 1998), lung 
mass (Speck et al., 2008), granulomatous mastitis (Nath 
et al., 2013) and endophthalmitis (Ebersole & Paturzo, 
1988) were also seen especially in immunocompromised 
human patients. Highest mortality rate has been reported 
among HIV patients, intermediate rate among non-HIV 
immunocompromised patients and lowest rate was 
reported among the immunocompetent patients (Kedlaya 
et al., 2001). They also reported overall mortality rate of 
25% in human patients infected with R. equi. Tables 1, 2, 
and 3 elaborate the comparative clinical signs, affected 
organs and extra-pulmonary signs in human, horses and 
cats from previously documented reports and reviews 
 
DIAGNOSIS OF R. Equi INFECTION  
 
Just based on the major (pneumonia) or minor 
(extra-pulmonary lesions) clinical signs, it is not possible 
to diagnose disease associated with R. equi, unless patient 
belongs to an endemic area but still other infections 
possessing similar clinical signs can be overlooked (Barrs 
& Beatty, 2009; Prescott & Hoffman, 1993). A number of 
tests can be used in disease diagnosis like complete blood 
count, blood chemistry parameter like fibrinogen, 
radiological procedures like radiographs, and serological 
tests like enzyme-linked immunosorbent essay (ELISA). 
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Table 1: Clinical signs of R. equi infection in different species 
 
Symptoms Humans No. (%) Horses No. (%) Cats No. (%) 
Fever 61 (91) 109 (68) 55 (12.5) 
Cough 59 (88.1) 115 (71) 21 (16.7); 55 (12.5) 
Pneumonia/ Bronchopneumonia 64 (95)/-- 161 (100)/-- 536 (90); 3Group of kittens 
Abnormal lungs sound -- 75 (47) 21 (16.7); 511 (27.5) 
Expectoration 57 (85.1) -- -- 
Chest Pain 30 (44.8) -- -- 
Haemoptysis 21 (31.3) -- -- 
Dyspnea/ Respiratory Failure 20 (29.8)/-- 70 (43)/-- 535 (87.5); 11 (100) 
Tachypnea -- 50 (31) 519 (47.5) 
Asthenia 17 (25.4) -- -- 
Weight loss 16 (23.9) -- 57 (17.5) 
Anorexia 12 (17.9) -- 526 (65) 
Diarrhea/ Gastroenteric signs 04 (06)/-- -- 52 (5); 11 (100) 
Headache 02 (03) -- -- 
Tumor 02 (03) -- 41 (09) 
Dysarthria 01 (1.5) -- -- 
Lethargy/ Depression -- 85 (53)/-- 58 (20) / 21 (16.7) 
Nasal discharge -- 50 (31) 52 (5) 
Polysynovitis -- 1 (0.6) -- 
Pyothorax -- -- 532 (80); 3*1 (100) 
Musculoskeletal manifestations -- -- 54 (10); 25 (83.3); 47 (63.6) 
Total number of cases 67 161 11 
26 
3Group of kittens; 3*1 
411 
540 
References (Torres-Tortosa et al., 2003) (Chaffin et al., 2011) 1(Passamonti et al., 2011), 2(Fairley & 
Fairley, 1999), 3(Gunew, 2002), 4(Shinji 
Takai et al., 2003), 5(Aslam et al., 2019) 
 
Table 2: Organ affected by R. equi in different species  
 
Affected Organs Humans No. (%) Horses No. (%) Cats No. (%) 
Lung 64 (95.5) 1161 (100) 536 (90); 1,2,33 (--) 
3*Group of kittens  
Pleura 10 (14.9) 25 (3) 532 (80); 3*1 (100) 
Peritoneum -- 211 (7) -- 
CNS 03 (4.5) 25 (3) 21 (16.7) 
Skin and soft tissue 03 (4.5) 28 (5) 25 (83.3) ; 47 (63.6)  
54 (10)  
Mediastinum 01 (1.5) -- 536 (90); 3*1 (100) 
Thyroid 01 (1.5) -- -- 
Liver 01 (1.5) 216 (11) 530 (75) 
Heart 01 (1.5) 26 (4) -- 
Blood 40 (59.8) 211 (7) 3*1 (100) 
Kidney -- 27 (5) 53 (7.5) 
Peripheral lymph node -- 211 (7) -- 
Intestines -- 250 (33) 11 (100); 52 (5) 
Joints -- 214 (9) -- 
Bone/Bone marrow -- 8 (5) -- 
Eye -- 216 (11) -- 
Total number of cases 67 1161 
2150 
11 
26 
3Group of kittens; 3*1 
411 
540 
References (Torres-Tortosa et al., 2003) 1(Chaffin et al., 2011) 
2(Reuss et al., 2009) 
1(Passamonti et al., 2011), 2(Fairley & 
Fairley, 1999), 3(Gunew, 2002), 4(Shinji 
Takai et al., 2003), 5(Aslam et al., 2019) 
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Table 3: Extrapulmonary signs for R. equi in different species 
 
Humans Horses n=150 (%) Cats 
Pyrexia Diarrhea 50 (33) 1Wound infection 
Diarrhea Immune mediated polysynovitis 37 
(25) 
1Subcutaneous abscess 
Abscessation of thyroid gland Ulcerative enterotyphlocolitis 31 
(21) 
1,5Soft tissue pyogranulomatous lesion 
Abscessation brain, 2kidney and 
2liver 
Intra-abdominal abscesses 25 (17) 1Vaginitis 
Abscessation of meninges Abdominal lymphadenitis 25 (17) 1,5Hepatitis 
Abscessation of peritoneum Uveitis 16 (11) 1Osteomyelitis 
Lymphadenitis (cervical, 
mesenteric) 
Pyogranulomatous hepatitis 16 (11) 1Myositis 
Pericarditis and 2ventricular shunt Septic synovitis 14 (9) 1,5Lymphadenitis mediastinal 
Osteomyelitis Mediastinal lymphadenitis 12 (8) 1Mesenteric lymphadenitis 
Synovitis Peritonitis 11 (7) 3Contaminated ulcerated tissue 
Colonic polyp Peripheral lymphadenopathy 11 (7) 2Depression 
Granulomatous mastitis Bacteraemia (R. equi) 11 (7) 2Lameness 
Endophthalmitis Subcutaneous abscesses 8 (5) 2Firm swelling of legs 
Bacteraemia (Rhodococcus equi) Pyogranulomatous nephritis 7 (5) -- 
2Spontaneous pneumothorax Hyperthermia 6 (4) -- 
2Traumatic keratitis Pericarditis 6 (4) -- 
2Peritonitis (dialysis related) Osteomyelitis 5 (3) -- 
2Septic arthritis Pleural effusion 5 (3) -- 
2Urinary tract infection Granulomatous meningitis 5 (3) -- 
2Prostate abscess Vertebral body osteomyelitis 3 (2) -- 
2Spleen abscess Paravertebral abscess 3 (2) -- 
2Otomastoiditis Cellulitis/lymphangitis 2 (1) -- 
2Broncho-biliary fistula Immune-mediated haemolytic 
anaemia 2 (1) 
-- 
(Khurana, 2015) 
2(Weinstock & Brown, 2002) 
(Reuss et al., 2009) 1(Passamonti et al., 2011), 2(Fairley & Fairley, 
1999), 3(Shinji Takai et al., 2003), 4(Aslam et al., 
2019) 
 
to distinguish R. equi pneumonia from other aetiologies 
(Steeve et al., 1997). Radiography and computed 
tomography scan (CT Scan) are also used in human cases 
as supportive diagnostic aids (Kedlaya et al., 2001; 
Stewart et al., 2019). Consensus statements of American 
College of Veterinary Internal Medicine (ACVIM), 
however, consider microbiological culture in conjunction 
with polymerase chain reaction (PCR) for amplification 
of VapA gene as the gold standard. Samples can be 
collected by tracheobronchial aspiration (TBA) or trans-
tracheal wash (TTW) for bronchopneumonia and from the 
sites of extra-pulmonary lesions. For inclusion criteria, 
supportive clinical signs, cytological and radiological aids 
should be considered for bronchopneumonia cases of 
horses to run these diagnostics (S. Giguère et al., 2011; 
Heidmann et al., 2006). 
 
Radiological findings in different species 
 
In previous human studies containing radiological 
findings related to R. equi infection, there is a 
contradicting statement regarding upper lung lobe 
infection being the most common or preferred site. 
Previous studies (Muntaner et al., 1997; Yamshchikov et 
al., 2010) documented cavitary lesion oriented upper lung 
lobes pneumonia as most common finding, but (Kedlaya  
 
et al., 2001) negated this statement because of almost-
equal involvement of upper, middle and lower lung lobes 
in their study. Furthermore, in a previous retrospective 
study for evaluation of R. equi infection in 67 HIV-
infected human patients, revealed more or less same 
results for all lung lobes without any preferred or most 
common predilection site. Chest radiographs were 
abnormal in 97% cases with 67% containing cavitary 
lesions. Involvement of multiple lobes, pleural effusion 
and mediastinal lymph nodes was noticed in 19%, 16%, 
and 3% cases, respectively (Torres-Tortosa et al., 2003). 
Another study (Kedlaya et al., 2001) also reported 
62% patients with pneumonia findings on radiographs but 
reasonably low (5%) pleural effusion findings as 
compared to that of Torres-Tortosa et al., (2003) where it 
was 16%, although sample size was smaller (19 cases) in 
this study. Broncho-biliary fistula was also noticed in 5% 
cases. Thick walls with air or fluid filled spaces are 
characteristics of cavities formed with R. equi infection 
(Cornish & Washington, 1999).  
In another retrospective study of 48 human cases, 
abnormal radiographic findings were noticed in 100% of 
cases and cavitation was reported in 77% radiographs. 
This study concluded a criteria for strongly suspected 
immunocompromised (AIDS, HIV patients) candidates 
infected with R. equi. And included parameters were low 
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CD4 lymphocytes (<200 mm3), cavitary lesion in chest 
radiographs especially in upper lobe region and subacute 
onset with poor response to conventional antibiotic 
therapy (Muntaner et al., 1997). CT scan and magnetic 
resonance imaging (MRI) is more sensitive to 
characterize lesions associated with R. equi infection 
(Marchiori et al., 2005; Nath et al., 2013).  
Radiography is considered one of the most 
frequently used diagnostic technique for foals suspected 
to be infected with R. equi (Steeve Giguère & Prescott, 
1997). A predominant alveolar pattern with regional 
consolidation and abscess/es characterized by discrete 
nodular or gas filled cavitary lesion are commonly seen in 
foals infected with this bacterium. Dorsal displacement of 
trachea was also reported because of tracheobronchial 
lymphadenopathy. Syndrome of sporadic 
bronchointerstitial pneumonia (severe dyspnea and 
radiographically bronchointerstitial pattern) can be a 
sequalae of R. equi related pneumonia (Lakritz et al., 
1993). Thoracic abscess as a feature of radiological 
diagnosis of R. equi infection has sensitivity of 71% and 
specificity of 85% in foals (Leclere et al., 2011). A 
distinct reticulonodular lesion type miliary pattern was 
also reported in one of the previous study where R. equi 
was a concurrent infection with another bacteria 
(Ainsworth et al., 1993). 
Ultrasonography is a useful technique for screening 
foals at earlier stage of disease (Gary Muscatello, 2012b) 
but the only drawback is it can demonstrate superficial 
lesions. Comet tail appearance of the lung fields and fluid 
or air-filled pockets raise index of suspicion for 
veterinarian to look for further radiological and diagnostic 
procedures for the diagnosis of pneumonia in foals at 
early stages (Ramirez et al., 2004; Slovis et al., 2005). 
Manifestations on thoracic radiographs depend on the 
clinical progression of the disease. Initial stages of 
disease can show an interstitial pattern and/or 
consolidation but in advanced stages of infection nodular 
pattern of variable size is seen on chest radiographs 
(Heidmann et al., 2006). As some cases of R. equi 
pneumonia can display bronchointerstitial pattern only 
without any evidence of abscess on radiographs, in such 
cases CT scan and MRI can be the more sensitive and 
useful tools to characterize lesions. These advanced 
modalities are best in the diagnosis of extra-pulmonary 
lesions, for instance brain abscess caused by these 
bacteria. In a previous study, CT scan was used to 
diagnose a mediastinal abscess caused by R. equi in a foal 
(Wion et al., 2010). 
Currently, there is only one study on radiological 
feature of this disease in cats where mixed alveolar-
interstitial, pleural effusion, hepatomegaly, thoracic 
lymphadenopathy, atelectasis of any lung lobe, 
consolidation of any lung lobe, cavitary or mass opacity 
lesions and pneumothorax were predominant findings 
(Aslam et al., 2019). Also, it is hypothesized that this 
infection causes more extra-pulmonary disease in cat host 
instead of pulmonary infection (Passamonti et al., 2011). 
Barrs & Beatty (2009) reviewed new insights in the 
investigation of feline pyothorax and documented that 
less than twenty percent of cases occurred because of 
unusual bacteria like R. equi, E. coli, Nocardia spp., 
Salmonella spp., Proteus, Pseudomonas and Klebsiella 
spp. Pleural effusion with rounding of costophrenic 
angles and retraction of lung lobes from thoracic wall and 
prominent lobar edges and fissure are therefore 
characteristics of chest radiographs of cats with 
pyothorax. Abscess or cavitary lesions on lung tissues and 
pyothorax have been reported in a cats infected with R. 
equi (Aslam et al., 2019; Gunew, 2002). Abnormalities in 
the tracheobronchial and retrosternal lymph nodes and 
abdominal organs especially liver and kidney have been 
reported in a recent studies of cats diagnosed with R. equi 
(Aslam et al., 2019; Passamonti et al., 2011).  
 
Haematology and biochemistry findings in different 
species 
 
In human patients, haematological and biochemical 
findings are not specific nor sensitive for R. equi because 
of the opportunistic type of infection in already sick or 
immunocompromised patients. An average white blood 
cell (WBC) count in human cases documented 8.1 x 
109/L with a range of 3.8 – 19.1 x 109/L (Doig et al., 
1991). CD4+ has been checked in many previous studies 
and looked retrospectively also with an average of 35/µL 
(range 01–183/µL). Most of the time, this infection 
occurs in HIV patients with <200/µL CD4+ cells and 
chronic pulmonary cavitary lesion/s  (Torres-Tortosa et 
al., 2003; Vechi et al., 2018). None of the previous 
human study on R. equi could demonstrate any consistent 
striking biochemistry pattern. 
Steeve Giguère & Prescott (1997) described 
complete blood count (CBC) with hyperfibrinogenaemia 
(consistent finding) and biochemistry profiles highly 
useful parameters to raise the index of suspicion in foals 
infected with R. equi with supportive clinical signs. 
Another study also (Leclere et al., 2011) reported a 
specificity of 86% for white blood cells and 92% for 
fibrinogen if leukocyte count is >20,000 cells/µL and 
hyperfibrinogenaemia of >700 mg/dL. In differential cell 
count, neutrophilia with or without monocytosis was most 
a common finding.  
Previous study (Steeve Giguère et al., 2003) 
reported that white blood cell count has significantly 
greater diagnostic performance as compared to fibrinogen 
concentration in foals. These parameters have lots of 
variations when compared with cases of similar clinical 
signs produced by other infectious agents. 
Thrombocytosis can be seen with acute or chronic 
inflammation and it was reported as significant parameter 
in foals infected with In R. equi, but this was also 
declared quite a variable parameter later on (Steeve 
Giguère & Prescott, 1997). Elevated globulin levels were 
also seen in some cases of foals (Hines, 2014). Increased 
white blood cells are significantly correlated with EPDs 
of foals. Cases of foals with bronchopneumonia or with 
non-specific clinical signs carrying significantly high 
number of WBCs should warrant further detailed 
investigation to look for EPDs (Reuss et al., 2009). 
Based on the reported clinical signs in previously 
available studies, neutrophilic changes with left shift ± 
monocytosis and/or lymphocytosis and mild to moderate 
anaemia can be possible findings in haematology as it is 
consistently seen in infectious feline pyothorax (Barrs et 
al., 2005; Demetriou et al., 2002). Neutropenia can also 
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be seen in cases with degenerative left shift (Barrs & 
Beatty, 2009). Common serum biochemistry profile 
changes in cats diagnosed with pyothorax are, 
hypoalbuminaemia with hyperglobulinaemia, low 
sodium, chloride and calcium levels and mild elevations 
of aspartate aminotransferase (AST) and bilirubin level 
(Barrs & Beatty, 2009; Demetriou et al., 2002). 
Leukocytosis because of neutrophilia with/without left-
shift, monocytosis and thrombocytopenia were prominent 
findings in hematology reports of cats infected with R. 
equi. In serum biochemistry changes in the proteins level 
were predominant findings causing low albumin to 
globulin ratio (Aslam et al., 2019). 
 
Cytological findings 
 
Cytology is considered as supportive diagnostic 
along with microbiological culture. Cytological 
characteristics are described quite similar in all reported 
species. An intra- or extracellular gram-positive 
pleomorphic (cocci to coccobacillus) rod on cytological 
evaluation of infected or contaminated specimen supports 
the presence of R. equi (Heidmann et al., 2006; Hines, 
2014). In foals, identification of these bacteria is highly 
specific (91%) from tracheal aspirate but sensitivity 
(35%) of the test is quite poor (Leclere et al., 2011). 
Commonly these bacteria are seen in histiocytes, 
macrophages and neutrophils on cytological examination 
as shown here in Figure 1. In previous studies of different 
species, intrahistiocytic presence was reported in goat 
sample (Stranahan et al., 2018), macrophages and 
neutrophils carrying pleomorphic bacteria had been 
reported in dogs (Bryan et al., 2017) and cats (Fairley & 
Fairley, 1999). It is not necessary that bacteria will be 
present in all cytological samples as they can be low in 
number or may be difficult to detect. On a routine basis, a 
 
Figure 1. A cytological smear of R. equi from thoracic 
fluid of a cat presented with severe respiratory 
distress due to bilateral pleural effusion. 
Pyogranulomatous inflammation was diagnosed due 
to the presence of abundant neutrophils and 
macrophages. Pleomorphic phagocytosed bacteria 
noticed in macrophage. (1000x, Wright’s stain, UVH, 
FPV, UPM, Malaysia)  
combination of cytology of tracheal aspirate and 
microbiological culture can be adapted as valuable tools 
to improve the quality of diagnosis. In a previous study,  
confirmed R. equi was cultured for 48 samples but only 
61% of the samples were positive on tracheal aspirate 
cytology (Anzai et al., 1997; Sweeney et al., 1987). 
 
Pathological findings in different species 
 
A typical and common R. equi lesion is abscesses 
formation in pulmonary parenchyma (McCracken, 2015). 
In humans also pneumonia is the most common 
presentation which is further confirmed by radiological 
procedures and cytological examination of samples of 
lesions on lung parenchyma. Necrotizing pneumonia with 
abscess formation is characteristic lesion in pulmonary 
form (Emmons et al., 1991). This lesion, 
histopathologically termed as malakoplakia (acquired 
granulomatous disease) is characterized by heavy 
infiltration of histiocytes and concentric scattered 
basophilic Michaelis-Gutmann bodies (Alfano et al., 
2019). Histopathology of extra-pulmonary lesions were 
also described in human reports, where biopsies taken 
from caecum, ascending and transverse colon showed 
similar type of cellularity and heavy infiltration of 
histiocytes (Hamrock et al., 1999).  
In foals, because of the virulence-associated severity 
and endemic nature of the disease, lesions are well 
described and demonstrated in previous studies. Firm 
nodular lesions were seen as in multiple dispersion or 
giant coalescing form, are characteristics of gross lung 
lesions. These lesions (often described as abscess) are 
separated from atelectatic or congested lung lobes. 
Miliary pyogranulomatous lesions can also be seen in 
some cases. Distribution can vary on both sides of the 
lungs or it can be throughout the lungs. Sometimes 
pleural fluid is also noticed. Thoracic lymphadenopathy is 
often seen in such cases, characterized by oedematous, 
caseous and necrotic in appearance (Hines, 2014).  
Histopathologically in foals, bronchiolitis, necrosis 
of alveolar septum with infiltration of macrophages, giant 
cells and neutrophils are seen at earlier stages with or 
without engulfed intact bacteria. Lymphocytes and 
plasma cells are also seen in interstitial zones and alveolar 
septum. In later stages, spectrum of alveolar septal 
necrosis increase in larger areas of the pulmonary 
parenchyma and produce caseous necrotic material 
termed as pyogranulomatous lesions. Oedema, 
congestion, interstitial fibrosis and hyperplasia of type II 
pneumocytes are also noticed commonly in 
histopathological lesions (Hines, 2014; Lakritz et al., 
1993). Pyogranulomatous and/or suppurative lesions are 
usually seen in most of the extra-pulmonary disorders 
listed in Table 3. 
With regards to cats, similar type of cell population 
was noticed in lung and subcutis histology in previously 
reported cases. Alveolar septal necrosis, detached 
pneumocytes, macrophages engulfing pleomorphic 
bacteria, neutrophils, giant cells, lymphocytes and plasma 
cells were noticed in histopathological section of lung 
(Passamonti et al., 2011). In subcutis histopathological 
section, macrophages engulfing pleomorphic bacteria 
with clear cytoplasm and neutrophils were reported 
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(Fairley & Fairley, 1999). In a single cat study, report of 
gross lung lesions appearance for R. equi infection was 
white foci scattered multifocally all over the lungs field 
with increased consistency without any prominent 
consolidation. Mucopurulent exudate and mild oedema 
were noticed from cut surfaces of the lung lobes. 
Tracheobronchial lymphadenopathy, pale colour enlarged 
liver and renomegaly were also reported in the same 
study (Passamonti et al., 2011). 
 
TREATMENT CONTROL AND PREVENTION 
 
Generally, best medical practice is to preform 
antibiotic susceptibility test for the rationale use of 
antimicrobial therapy in all species presented with 
infectious diseases. In humans, despite the use of broad 
spectrum, lipophilic antibiotics with high penetration 
ability, mortality rate is still high as most of the cases 
carry concurrent immunosuppressive disorders (Donisi et 
al., 1996). R. equi is an intracellular pathogen and 
replicating in macrophages, hence antibiotics having good 
penetrating ability in cells and have strong lipophilic 
properties are tested as best treatment choices. Many 
drugs show high in-vitro sensitivity but are reasonably 
poor in in-vivo efficacy, as demonstrated by a previous 
study where penicillin and gentamicin therapies resulted 
in high mortality, despite tested as highly sensitive drugs 
against R. equi strain in infected foals (Sweeney et al., 
1987). 
A wide range of antibiotics have been shown to be 
effective in many reported cases and retrospective studies 
in the past (Kedlaya et al., 2001) but combination of 
macrolide (erythromycin, azithromycin, clarithromycin) 
and rifampin remain the therapy of choice for R. equi 
infection in humans and horses (S. Giguère et al., 2011; 
Steeve Giguère & Prescott, 1997; Khurana, 2015). In this 
combination, clarithromycin-rifampin is superior as 
compared to azithromycin and erythromycin with 
rifampin (Giguére et al., 2004). In cats, amoxicillin, 
gentamicin and lincomycin have been recommended in 
previously reported studies (Passamonti et al., 2011). 
Gunew (2002) used doxycycline to treat R. equi related 
pyothorax in a cat. Fairley & Fairley (1999) tested 
combination of erythromycin and rifampin in a cat 
diagnosed with R. equi and proved effective. In the same 
study, another four cats were treated successfully with 
amoxicillin clavulanic-acid combination for 
musculoskeletal pathologies related to R. equi. Aslam et 
al., (2019) reported significant resistance in cats tested 
against cephalexin, clindamycin, tetracycline, 
metronidazole and potentiated amoxicillin as treatment 
choices for R. equi. On the other hand combinations of 
the rifampin with macrolides and/or fluoroquinolones 
were considered acceptable options as some cases 
improved and/or recovered with these combinations. Only 
antimicrobial therapy is not sufficient for management of 
feline rhodococcosis cases a number of factors can impart 
in final outcome of disease like pyothorax management 
and oxygen therapy. 
Since 2007, significant increase in resistance (P 
<0.001) of R. equi towards erythromycin and rifampin is 
seen especially from tracheobronchial aspirate, lungs and 
musculoskeletal samples in foals (Huber et al., 2018). 
Consensus statements of the ACVIM suggested poor or 
worse prognosis for foals infected with resistant strains of 
R. equi (S Giguère et al., 2011).  
In humans, mortality rate depends on the immune 
status of the host and reported almost 11%, 50 – 55% and 
20 – 25% in immunocompetent, HIV-infected 
immunodeficient and non-HIV immunodeficient cases, 
respectively (Kedlaya et al., 2001). An overall survival 
rate of 60 – 90% reported with current amicrobial 
therapies with their resistance status in foals (Hines, 
2014). On the other hand, an overall survival rate of 72% 
was reported in another retrospective study (Ainsworth et 
al., 1998) from 115 foal cases. In cats, data about survival 
and outcome is quite variable because of limited number 
of cases and studies. Most of the cases with extra-
pulmonary disorders survived and responded well to 
antibiotics as compared to pulmonary cases where only 
one study showed complete resolution of pulmonary 
manifestation (Fairley & Fairley, 1999; Gunew, 2002; 
Passamonti et al., 2011). On the other hand, Aslam et al., 
(2019) reported a recovery rate of only 32.5% in 40 cats 
diagnosed with pulmonary and extra-pulmonary form of 
the disease. In the same study all 4/4 cats with cutaneous 
form of the disease died because of the poor response to 
antimicrobial therapy. 
Control and preventions are very important and 
documented well in natural host of this bacterium because 
of the severity of the diseases and losses attached with 
this infection but weightage is not given in human host 
studies as it is opportunistic for them. In cats, there are no 
data available on control and prevention. In human cases, 
prophylactic usage of macrolides against mycobacterium 
tuberculosis complex in immunocompromised hosts 
might have also given some support to control this 
infection. Exposure should be reduced as much as 
possible and infected patients should be isolated to 
prevent nosocomial spread (Weinstock & Brown, 2002). 
While in foals, screening tests for example, white blood 
cell count and ultrasound for early detection of the 
disease, environmental management, active and passive 
immunization, and chemoprophylaxis are control and 
preventive methods documented comprehensively by 
Hines (2014) and also recommended by consensus 
statements of American College of Veterinary Internal 
Medicine (S. Giguère et al., 2011). 
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